Gene Delivery Using Viral Vectors - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 257

Acknowledgment

The authors acknowledge the financial assistance from funding agency of research
scholar and TIFAC CORE in NDDS, Government of India, New Delhi, for providing
the research facilities to the team.

References

[1] Carter BJ. Viral vectors for gene therapy. In: Rehm HJ, editor. Biotechnology: a multi-
volume comprehensive treatise, Wiley-VCH; 1991. p. 399-425.
[2] P﻽ter G, Halsey NA. American Academy of Pediatrics. Report of the Committee on [2] P﻽ter G, Halsey NA. American Academy of Pediatrics. Report of the Committee on

Infectious Diseases Adenovirus Infections. In: Peter G, editor. Red book. 24th ed. Elk
Grove Village, IL: American Academy of Pediatrics; 1997:131.
[3] Horwitz MS. Adeno 570 viruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields [3] Horwitz MS. Adeno 570 viruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields

virology. Philadelphia, PA: Lippincott-Raven; 1995. p. 2149-71.
[4] Foy HM. Adenoviruses: viral infections in humans. In: Evans A, Kaslow R, editors. [4] Foy HM. Adenoviruses: viral infections in humans. In: Evans A, Kaslow R, editors.

Epidemiology and control. New York, NY: Plenum; 1997. p. 119-38.
[5] Wolff JA. Gene therapeutics: methods and applications of direct gene transfer. In: Wolff [5] Wolff JA. Gene therapeutics: methods and applications of direct gene transfer. In: Wolff

JA, editor. Gene therapeutics. Cambridge, MA: Birkhäuser Boston; 1994:417.
[6] Wang M, Zheng X, Rao XM, Hao H, Dong Y, Kelly M, et al. Review article. Adenoviral [6] Wang M, Zheng X, Rao XM, Hao H, Dong Y, Kelly M, et al. Review article. Adenoviral

vector systems for gene therapy. Gene Ther Mol Biol 2005;9:291-300.
[7] Danthinne X, Imperiale MJ. Viral transfer technology review article production of first

[7] Danthinne X, Imperiale MJ. Viral transfer technology review article production of first
generation adenovirus vectors: a review. Gene Ther 2000;7:1707-14.
[8] Graham FL. Manipulation of adenovirus vectors. In: Murray EJ, editor. Gene transfer and [8] Graham FL. Manipulation of adenovirus vectors. In: Murray EJ, editor. Gene transfer and

expression protocols—methods in molecular biology, vol 7. Totowa, NJ: Humana Press;
1991. p. 109-28.
[9] Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line trans- [9] Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line trans-

formed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-74.
[10] Graham FL. Growth of 293 cells in suspension culture. J Gen Virol 1987;68:937-40.
[11] Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P. Evaluation of
the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus
vector. Hum Gene Ther 1990;1:241-56.
[12] Quantin B, Perricaudet LD, Tajbakhsh S, Mandel JL. Adenovirus as an expression vector
in muscle cells in vivo . Proc Natl Acad Sci U.S.A. 1992;89:2581-4.
[13] Engelhardt JF, Yang Y, Stratford-Perricaudet LD, Allen ED, Kozarsky K, Perricaudet M,
et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts
with E1-deleted adenoviruses. Nat Genet 1993;4:27-34.
[14] McElvaney NG. Is gene therapy in cystic fibrosis a realistic expectation? Curr Opin Pulm
Med 1996;2:466-71.
[15] Van Ginkel FW, McGhee JR, Liu C, Simecka JW, Yamamoto M, Frizzell RA, et al.
Adenoviral gene delivery elicits distinct pulmonary associated T helper cell responses to
the vector and to its transgene. J Immunol 1997;159:685-93.
[16] Shenk T, Jones N, Colby W, Fowlkes D. Functional analysis of adenovirus-5 host-range
deletion mutants defective for transformation of rat embryo cells. Cold Spring Harb
Symp Quant Biol 1980;44:367-75.
[17] Morral N, Parks RJ, Zhou H, Langston C, Schiedner G, Quinones J, et al. High doses
of a helper-dependent adenovirus vector yield supraphysiological levels of a1-antitrypsin
with negligible toxicity. Hum Gene Ther 1998;9:2709-16.